The recognition of COVID-19 vaccine injuries remains a complex and often contentious issue across Europe. In the German state of Hesse, authorities have acknowledged a relatively small number of claims for damages allegedly linked to coronavirus vaccinations, even as the number of legal challenges continues to rise. This situation highlights the difficulties in establishing a causal link between vaccination and reported health problems, and the varying approaches taken by different regions in addressing these concerns.
As of May 14, 2025, a total of 184 lawsuits concerning alleged COVID-19 vaccine injuries had been filed with social courts in Hesse, according to reporting from Frankfurter Rundschau. While a significant number of these cases have been withdrawn (13) or dismissed by the courts (6), only one case has seen a favorable ruling for the claimant in the initial instance. However, that ruling is currently under appeal, meaning a final decision is still pending at the Landessocialgericht (State Social Court) in Darmstadt.
Limited Recognition of Vaccine Injuries
The limited number of recognized vaccine injuries in Hesse reflects a broader trend across Germany and other European countries. Establishing a direct causal link between a vaccine and a subsequent health issue is often challenging, requiring extensive medical evaluation and legal scrutiny. The standard for proving a vaccine injury is high, requiring demonstrable evidence that the vaccine directly caused the reported health problem, and not pre-existing conditions or other factors.
According to Jutta Mauer, a judge and spokesperson for the Landessocialgericht in Darmstadt, the lawsuits filed in Hesse are not directed at the vaccine manufacturers themselves, but rather at the state authorities who issued the vaccination recommendations during the pandemic. This suggests that claimants are seeking compensation from the state based on the argument that the vaccination recommendations were flawed or that the risks were not adequately communicated.
Ongoing Legal Battles and Appeals
The two pending cases at the Landessocialgericht represent a continuation of the legal battles surrounding COVID-19 vaccine injuries. In these cases, the court is examining whether health impairments following a COVID-19 vaccination can be recognized as vaccine injuries under the terms of the social compensation law. One case involves a 76-year-old man from Frankfurt with pre-existing conditions, who claimed the vaccine exacerbated a pre-existing gait impairment. The initial claim was rejected due to the pre-existing nature of his condition, a decision he appealed. The second case concerns a 51-year-old man from the Landkreis Waldeck-Frankenberg who developed myocarditis shortly after receiving the Janssen vaccine. While a lower court initially ruled in his favor based on a cardiological assessment suggesting a possible link, the decision is now being challenged.
The legal proceedings highlight the complexities of assessing causality in cases of alleged vaccine injuries. The court must weigh medical evidence, consider pre-existing conditions, and determine whether the vaccine was a substantial contributing factor to the reported health problems. The requirement of establishing a “sufficient probability” of a causal link, as stipulated by social compensation law, presents a significant hurdle for claimants.
Landessozialgericht Decisions in January 2026
Recent decisions from the Hessisches Landessozialgericht (Hessian State Social Court) in January 2026 further illustrate the challenges in securing recognition for COVID-19 vaccine injuries. In two separate cases, the court ruled that there was insufficient evidence to establish a causal connection between health complaints and COVID-19 vaccination. The court emphasized that the requirements of the social compensation law were not met in either instance.
One case involved the 76-year-old man from Frankfurt, who already had a disability rating of 80% due to pre-existing spinal issues and lymphedema. The court found that his reported gait impairment was likely related to his pre-existing conditions, rather than the vaccine. The second case involved the 51-year-old man with myocarditis. While a lower court had initially sided with the claimant based on a cardiologist’s opinion suggesting a possible link, the Landessozialgericht overturned that decision, finding the causal connection insufficiently proven.
Broader Context: Vaccine Injury Compensation Schemes
The situation in Hesse is part of a wider debate about vaccine injury compensation schemes and the responsibility of governments and pharmaceutical companies in addressing adverse events following vaccination. Many countries have established programs to provide financial assistance to individuals who have suffered demonstrable harm as a result of vaccination. However, these programs often have strict eligibility criteria and can be difficult to navigate.
In Germany, the Vaccine Injury Compensation Program (Impfschadenhilfe) provides financial support to individuals who have suffered serious health consequences as a direct result of vaccination. However, the program has been criticized for its limited scope and the difficulty in proving causality. The program is administered by the Federal Office for Social Security (Bundessozialamt) and requires a thorough medical assessment to determine eligibility. The program’s criteria are stringent, and many claims are rejected due to insufficient evidence of a causal link.
Challenges in Proving Causality
The core challenge in these cases lies in proving causality. Vaccines, like all medical interventions, carry a risk of side effects. However, distinguishing between a side effect directly caused by the vaccine and a health problem that occurs coincidentally after vaccination can be extremely difficult. Factors such as pre-existing conditions, genetic predisposition, and lifestyle choices can all play a role in the development of health problems, making it challenging to isolate the vaccine as the sole cause.
Medical experts often rely on statistical analysis and epidemiological studies to assess the risk of vaccine-related adverse events. However, these studies can be complex and may not always provide definitive answers. The reporting of adverse events can be incomplete, making it difficult to accurately assess the true incidence of vaccine-related injuries.
What Happens Next?
The cases currently before the Landessocialgericht in Darmstadt are expected to be decided in the coming months. These rulings will likely set a precedent for future cases involving alleged COVID-19 vaccine injuries in Hesse and potentially influence decisions in other German states. The outcomes will be closely watched by claimants, legal experts, and public health officials alike.
Beyond the legal proceedings, the debate over vaccine injury compensation and the recognition of adverse events is likely to continue. There is ongoing discussion about the need for more transparent and accessible compensation schemes, as well as improved systems for monitoring and reporting vaccine-related adverse events. The goal is to strike a balance between protecting public health through vaccination and providing support to individuals who may have suffered harm as a result.
The next key development will be the Landessozialgericht’s rulings on the two appealed cases. These decisions are anticipated to provide further clarity on the criteria for establishing a causal link between COVID-19 vaccination and health impairments. Readers seeking more information on vaccine injury compensation in Germany can consult the website of the Bundessozialamt.
Do you have thoughts on the challenges of proving vaccine injury? Share your comments below, and please share this article with your network.
Related reading